Phase II studies of gemcitabine for non-small cell lung cancer in Japan.

Seminars in oncology

Volumn 24, Issue 2 Suppl 7, 1997, Pages

  Fukuoka, M ^a   Takada, M ^a   Yokoyama, A ^a   Kurita, Y ^a   Niitani, H ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE; GEMCITABINE; RIBONUCLEOTIDE REDUCTASE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DRUG ANTAGONISM; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; JAPAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MIDDLE AGED; PHASE 2 CLINICAL TRIAL;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, NON-SMALL-CELL LUNG; DEOXYCYTIDINE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; JAPAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; RIBONUCLEOTIDE REDUCTASES;

EID: 0031112334     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)